Human ras-related oncogenes unmasked by expression cDNA cloning
US5792638A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | May 24, 1994 |
| Grant date | Aug 11, 1998 |
| Priority date | — |
| Expiry date | May 24, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The oncogene of the present invention, isolated by expression cloning from a human ovarian cancer is a mutant of TC21. The present invention teaches that ras-related genes not thought to have transforming potential can contribute importantly to cancers which have been refractory to oncogene detection. The present invention teaches that another ras relative gene, R-ras, which was previously reported to lack transforming potential, has transforming capacity as well. Thus, these and other genes similarly related to prototype and activated by analogous mechanisms may be important in the diagnosis and prognosis of certain cancers, as well as be critical in the design of rational approaches to therapy of cancers in which they play a role.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.